Cytokine | n | Reference(s) | Number of Studies indicating significant (p < 0.05) increases (‘n’, author(s)) | Number of Studies indicating significant (p < 0.05) decreases (‘n’, author(s)) |
---|---|---|---|---|
CCL2 | 6 | 0 | 0 | |
CCL3 | 5 | 0 | 0 | |
CCL4 | 5 | 0 | 0 | |
CCL5 | 5 | 1 [24] | 0 | |
CCL7 | 2 | 0 | 0 | |
CCL11 | 5 | 0 | 0 | |
CCL13 | 1 | [24] | 0 | 0 |
CCL17 | 1 | [24] | 0 | 0 |
CCL19 | 1 | [24] | 1 [24] | 0 |
CCL22 | 1 | [24] | 0 | 0 |
CCL24 | 1 | [24] | 1 [24] | 0 |
CCL26 | 1 | [24] | 0 | 0 |
CXCL-1 | 2 | 0 | 0 | |
CXCL-5 | 2 | 0 | 0 | |
CXCL-9 | 3 | 0 | 1 [25] | |
CXCL-10 | 5 | 0 | 0 | |
CX3CL-1 | 1 | [24] | 0 | 1 [24] |
FGF | 1 | [21] | 0 | 0 |
FGF-b | 3 | 0 | 0 | |
G-CSF | 4 | 0 | 0 | |
GM-CSF | 6 | 0 | 0 | |
HGF | 2 | 0 | 0 | |
IFN-α | 2 | 0 | 0 | |
IFN-α2 | 1 | [21] | 0 | 0 |
IFN-β | 2 | 0 | 0 | |
IFN-γ | 9 | 0 | 1 [28] | |
IL-1RA | 3 | 0 | 0 | |
IL-1α | 5 | 1 [20] | 0 | |
IL-1β | 9 | 1 [25] | ||
IL-2 | 7 | 0 | 0 | |
IL-3 | 1 | [28] | 0 | 0 |
IL-4 | 9 | 1 [20] | 0 | |
IL-5 | 7 | 1 [20] | 0 | |
IL-6 | 11 | |||
IL-7 | 6 | 1 [21] | 1 [25] | |
IL-8 | 12 | |||
IL-9 | 1 | [30] | 0 | 0 |
IL-10 | 10 | 0 | ||
IL-12p40 | 3 | 0 | 0 | |
IL-12p70 | 8 | 1 [20] | 0 | |
IL-12/23p40 | 1 | [24] | 0 | 0 |
IL-13 | 8 | 0 | 1 [20] | |
IL-15 | 6 | 0 | 1 [20] | |
IL-16 | 2 | 0 | 1 [24] | |
IL-17 | 6 | 0 | 0 | |
IL-17A | 1 | [21] | 0 | 1 [21] |
IL-17F | 2 | 0 | 0 | |
IL-23 | 2 | 0 | 0 | |
Leptin | 2 | 0 | 0 | |
LIF | 2 | 0 | 0 | |
LTα | 2 | 1 [20] | 0 | |
M-CSF | 2 | 0 | 0 | |
NGF | 1 | [31] | 0 | 0 |
β-NGF | 1 | [21] | 0 | 0 |
Resistin | 2 | 0 | 1 [25] | |
SCF | 2 | 0 | 0 | |
TNF-α | 11 | 1 [29] | 0 | |
TNF-β | 3 | 1 [32] | 0 | |
TGF-α | 2 | 0 | 0 | |
TGF-β | 3 | 1 [25] | 1 [22] | |
TGF-β1 | 1 | 1 [23] | 1 [34] | |
VEGF | 3 | 0 | 0 | |
VEGF-A | 2 | 0 | 1 [24] |